Serum Leptin, Adiponectin, and Resistin Concentration in Colorectal Adenoma and Carcinoma (CC) Patients

Overview

Journal Int J Colorectal Dis

Specialties Gastroenterology
General Surgery

Date 2008 Nov 4

PMID 18979105

Citations 60

Authors

Anna Kumor

Piotr Daniel

Miroslawa Pietruczuk

Ewa Malecka-Panas

Affiliations

Soon will be listed here.

Abstract

Introduction: Leptin, adiponectin, and resistin are the proteins secreted by adipocytes, which affects the metabolism. While the role of leptin in colon carcinogenesis is documented, the effect of adiponectin and resistin remains unclear. It has been indicated that while leptin may potentiate the cancer cells growth, adiponectin and resistin may act oppositely.

Aim: The aim of this study is to determine the concentration of leptin, adiponectin, and resistin in patients with adenomatous polyps and colorectal cancer.

Methods: The serum concentration investigated adipohormones had been measured with ELISA in 37 patients with colorectal adenomas, 36 with colorectal cancer (CC) and in 25 controls with no colorectal pathology. Endoscopically removed polyps and CC biopsies had been evaluated with histopathology. Mean BMI value was calculated for all patients.

Results: Among 37 adenomas, 25 revealed high-grade dysplasia (HGD) and 12 low-grade dysplasia (LGD). All cases of CC were adenocarcinomas. No difference in the level of investigated adipohormones in serum between patients with HGD and LGD polyps was observed. The serum concentration of leptin and adiponectin in CC patients was lower than in patients with adenomas (p < 0.05; p < 0.05, respectively) as well as in controls (p < 0.01; p < 0.05, respectively). The concentration of resistin in CC was not significantly different in the adenoma group (p > 0.05) but higher than in controls (p < 0.05). There was a correlation between adiponectin and leptin serum concentration (r = 0.61).

Conclusion: We conclude that serum concentration of adiponectin and resistin may play an important role in colon carcinogenesis. We also assume that leptin may possibly have the prognostic value useful in clinical practice and its concentration is independent of BMI value.

Citing Articles

Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions.

Wang T, Zhou D, Hong Z MedComm (2020). 2025; 6(1):e70030.

PMID: 39764565 PMC: 11702502. DOI: 10.1002/mco2.70030.

An Updated Review of Resistin and Colorectal Cancer.

Rompou A, Bletsa G, Tsakogiannis D, Theocharis S, Vassiliu P, Danias N Cureus. 2024; 16(7):e65403.

PMID: 39184804 PMC: 11344879. DOI: 10.7759/cureus.65403.

[Associations of circulating leptin levels with colorectal adenoma and colorectal cancer: a case-control and Mendelian randomization study].

Zhao H, Ling Y, Mi S, Zhu J, Fan J, Yang Y Nan Fang Yi Ke Da Xue Xue Bao. 2024; 43(12):1989-1997.

PMID: 38189383 PMC: 10774100. DOI: 10.12122/j.issn.1673-4254.2023.12.01.

Immunometabolic Profile Associated with Progressive Damage of the Intestinal Mucosa in Adults Screened for Colorectal Cancer: Association with Diet.

Gonzalez C, Ruiz-Saavedra S, Gomez-Martin M, Zapico A, Lopez-Suarez P, Suarez A Int J Mol Sci. 2023; 24(22).

PMID: 38003638 PMC: 10671025. DOI: 10.3390/ijms242216451.

Evaluation of Circulating Leptin and Its Receptor (Ob-R) Tissue Expression in Colorectal Cancer, a Report From North of Iran.

Mahmoudi-Nesheli M, Alizadeh-Navaei R, Vahedi L, Amjadi O, Taghvaei T, Maleki I Iran J Pathol. 2023; 18(3):299-305.

PMID: 37942199 PMC: 10628377. DOI: 10.30699/IJP.2023.1983482.3041.

References

Levy M, Visokai V, Lipska L, Topolcan O . Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma. 2008; 55(2):138-42. View

Rohrmann S, Platz E, Smit E, Giovannucci E . Re: Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol. 2004; 172(2):779. DOI: 10.1097/00005392-200408000-00099. View

Silswal N, Singh A, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham N . Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005; 334(4):1092-101. DOI: 10.1016/j.bbrc.2005.06.202. View

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H . Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005; 11(2 Pt 1):466-72. View

Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez J, Gutierrez C . Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004; 12(6):962-71. DOI: 10.1038/oby.2004.118. View

Wei E, Giovannucci E, Fuchs C, Willett W, Mantzoros C . Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst. 2005; 97(22):1688-94. DOI: 10.1093/jnci/dji376. View

Bray G . The underlying basis for obesity: relationship to cancer. J Nutr. 2002; 132(11 Suppl):3451S-3455S. DOI: 10.1093/jn/132.11.3451S. View

Lehrke M, Reilly M, Millington S, Iqbal N, Rader D, Lazar M . An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004; 1(2):e45. PMC: 529430. DOI: 10.1371/journal.pmed.0010045. View

10.

Mu H, Ohashi R, Yan S, Chai H, Yang H, Lin P . Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res. 2006; 70(1):146-57. DOI: 10.1016/j.cardiores.2006.01.015. View

11.

Arpaci F, Yilmaz M, Ozet A, Ayta H, Ozturk B, Komurcu S . Low serum leptin level in colon cancer patients without significant weight loss. Tumori. 2002; 88(2):147-9. DOI: 10.1177/030089160208800213. View

12.

Frankenberry K, Somasundar P, McFadden D, Vona-Davis L . Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg. 2004; 188(5):560-5. DOI: 10.1016/j.amjsurg.2004.07.031. View

13.

Beltowski J . Adiponectin and resistin--new hormones of white adipose tissue. Med Sci Monit. 2003; 9(2):RA55-61. View

14.

Ogunwobi O, Beales I . Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol. 2008; 285(1-2):43-50. DOI: 10.1016/j.mce.2008.01.023. View

15.

Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles J . Leptin expression in colorectal and breast cancer patients. Int J Mol Med. 2000; 5(4):421-6. DOI: 10.3892/ijmm.5.4.421. View

16.

Calabro P, Samudio I, Willerson J, Yeh E . Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation. 2004; 110(21):3335-40. DOI: 10.1161/01.CIR.0000147825.97879.E7. View

17.

Fukumoto J, Otake T, Tajima O, Tabata S, Abe H, Mizoue T . Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci. 2008; 99(4):781-6. PMC: 11158601. DOI: 10.1111/j.1349-7006.2008.00745.x. View

18.

Ukkola O . Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?. Eur J Endocrinol. 2002; 147(5):571-4. DOI: 10.1530/eje.0.1470571. View

19.

Jonsson F, Wolk A, Pedersen N, Lichtenstein P, Terry P, Ahlbom A . Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer. 2003; 106(4):594-599. DOI: 10.1002/ijc.11266. View

20.

Wang B, Jenkins J, Trayhurn P . Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab. 2004; 288(4):E731-40. DOI: 10.1152/ajpendo.00475.2004. View